Merck – Recall of Cubicin® (daptomycin)
On October 20, 2021 - The FDA announced a voluntary, user-level recall of one lot of Merck’s Cubicin (daptomycin) 500 mg injection because of a customer complaint reporting that a piece of glass was found in a vial of Cubicin after reconstitution.
Download PDF
